Temporal Arteritis (Giant Cell Arteritis): Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
add text here<br> | add text here<br> | ||
== Prevalence == | == Prevalence<br> == | ||
GCA is the most frequent primary vasculitis, which predominantly affects Caucasian people over the age of 50<ref name="chew" />. 95% of cases occur in patients older than 55 years<ref name="gurwood" />. Women are 2-6 times more likely to be affected than men<ref name="chew" /><ref name="gurwood" />. Giant cell arteritis occurs in 25% of all cases of polymyalgia rheumatica (PR)<ref name="book" />. GCA is more frequent among people of Scandinavian and Northern European descent<ref name="chew" />.<br> | |||
== Characteristics/Clinical Presentation == | == Characteristics/Clinical Presentation == |
Revision as of 03:41, 10 April 2016
Original Editors - Students from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Top Contributors - Kiersten Young, Savannah Lane, Lucinda hampton, Elaine Lonnemann, 127.0.0.1, WikiSysop, Kim Jackson and Sehriban Ozmen
Definition/Description[edit | edit source]
add text here
Prevalence
[edit | edit source]
GCA is the most frequent primary vasculitis, which predominantly affects Caucasian people over the age of 50[1]. 95% of cases occur in patients older than 55 years[2]. Women are 2-6 times more likely to be affected than men[1][2]. Giant cell arteritis occurs in 25% of all cases of polymyalgia rheumatica (PR)[3]. GCA is more frequent among people of Scandinavian and Northern European descent[1].
Characteristics/Clinical Presentation[edit | edit source]
add text here
Associated Co-morbidities[edit | edit source]
add text here
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Recent Related Research (from Pubmed)[edit | edit source]
Failed to load RSS feed from http://www.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1TUbR4JfRTvSrbbAM3hVX4olPV5UgCMCMh8k-36-4I7JL0BggL|charset=UTF-8|short|max=10: Error parsing XML for RSS
References[edit | edit source]
see adding references tutorial.
1. Chew S, Kerr N, Danesh-Meyer H. Giant cell arteritis. Journal of Clinical Neuroscience. 2009;16(10):1263-1268[1]
2. Gurwood A, Malloy K. Giant cell arteritis. Clinical and Experimental Optometry. 2002;85(1):19-26.[2]
3. Goodman C, Snyder T. Differential diagnosis for physical therapists. St. Louis, Mo.: Saunders/Elsevier; 2013. [3]
5. Smith J, Swanson J. Giant Cell Arteritis. Headache: The Journal of Head and Face Pain. 2014;54(8):1273-1289.[4]
6. Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N. Incidence of Giant Cell Arteritis and Characteristics of Patients: Data-Driven Analysis of Comorbidities. Arthritis Care & Research. 2015;67(3):390-395.[5]
- ↑ 1. Chew S, Kerr N, Danesh-Meyer H. Giant cell arteritis. Journal of Clinical Neuroscience. 2009;16(10):1263-1268
- ↑ 2. Gurwood A, Malloy K. Giant cell arteritis. Clinical and Experimental Optometry. 2002;85(1):19-26.
- ↑ 3. Goodman C, Snyder T. Differential diagnosis for physical therapists. St. Louis, Mo.: Saunders/Elsevier; 2013.
- ↑ 5. Smith J, Swanson J. Giant Cell Arteritis. Headache: The Journal of Head and Face Pain. 2014;54(8):1273-1289.
- ↑ 6. Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N. Incidence of Giant Cell Arteritis and Characteristics of Patients: Data-Driven Analysis of Comorbidities. Arthritis Care & Research. 2015;67(3):390-395.